148 related articles for article (PubMed ID: 28480839)
1. Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure.
Swanepoel AC; Emmerson O; Pretorius E
Microsc Microanal; 2017 Jun; 23(3):607-617. PubMed ID: 28480839
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Endogenous and Synthetic Estrogens on Whole Blood Clot Formation and Erythrocyte Structure.
Swanepoel AC; Emmerson O; Pretorius E
Microsc Microanal; 2017 Jun; 23(3):599-606. PubMed ID: 28478790
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes.
Emmerson O; Bester J; Lindeque BG; Swanepoel AC
Microsc Microanal; 2018 Dec; 24(6):713-728. PubMed ID: 30588913
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Hormones and Clot Formation.
Swanepoel AC; Visagie A; Pretorius E
Microsc Microanal; 2016 Aug; 22(4):878-86. PubMed ID: 27515365
[TBL] [Abstract][Full Text] [Related]
5. Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users.
Swanepoel AC; Bester J; de Lange-Loots Z
Microsc Microanal; 2020 Oct; 26(5):1007-1013. PubMed ID: 32778190
[TBL] [Abstract][Full Text] [Related]
6. Hemorheological mechanisms for increased thrombosis in subjects using gestodene.
Swanepoel AC; Roberts HC; Soma P; Lindeque BG; Bester J
Microsc Res Tech; 2018 Dec; 81(12):1489-1500. PubMed ID: 30365192
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the coagulation profile among oral and vaginal combined hormonal contraceptive users using sonoclot coagulation analyzer.
Brandy KR; Meyer RM; Luo X; Rao GH; Datta YH; Divani AA
Clin Appl Thromb Hemost; 2012 Nov; 18(6):576-81. PubMed ID: 22275394
[TBL] [Abstract][Full Text] [Related]
9. [Combined oral contraception and hypercoagulation].
Adukauskiene D; Miliauskiene V
Medicina (Kaunas); 2010; 46(4):293-7. PubMed ID: 20571299
[TBL] [Abstract][Full Text] [Related]
10. Effects of certain contraceptive hormones on blood coagulation.
Lorrain J; Harel P
Fertil Steril; 1972 Jun; 23(6):422-7. PubMed ID: 5030873
[No Abstract] [Full Text] [Related]
11. Oral contraceptives, ABO blood groups, and in vitro fibrin formation.
Fisch IR; Freedman SH
Obstet Gynecol; 1975 Oct; 46(4):473-9. PubMed ID: 1165884
[TBL] [Abstract][Full Text] [Related]
12. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.
Lau YC; Xiong Q; Lip GY; Blann AD
Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881
[TBL] [Abstract][Full Text] [Related]
13. Contraception, venous thrombosis and biological plausability.
Rott H
Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and the risk of venous thrombosis.
Vandenbroucke JP; Rosing J; Bloemenkamp KW; Middeldorp S; Helmerhorst FM; Bouma BN; Rosendaal FR
N Engl J Med; 2001 May; 344(20):1527-35. PubMed ID: 11357157
[No Abstract] [Full Text] [Related]
15. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
16. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
[No Abstract] [Full Text] [Related]
17. [Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
Lutsik LA
Sov Med; 1981; (2):52-5. PubMed ID: 7244809
[TBL] [Abstract][Full Text] [Related]
18. [Serious adverse effect of combined oral contraceptive pills among teenagers].
Nylander MC; Clausen HV
Ugeskr Laeger; 2014 Jun; 176(26):V05130336. PubMed ID: 25294576
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and arterial and venous thrombosis: a clinician's formulation.
Speroff L
Am J Obstet Gynecol; 1998 Jul; 179(1):S25-36. PubMed ID: 9704815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
